Home › Companies › The Oncology Institute, Inc. › 2025-2026
Compiled from SEC Form N-PX filings and The Oncology Institute, Inc.’s Form 8-K, filed 2026-06-18 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Proxy season: 2025-2026
Explore The Oncology Institute, Inc. in the interactive database Compare manager voting policies
These tallies are The Oncology Institute, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2026-06-18 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Brad Hively | 24,098,631 | -- | -- | 1,477,084 | 49,666,722 | Majority: yes |
| Elect Director: Karen Johnson | 23,014,174 | -- | -- | 2,561,541 | 49,666,722 | Majority: yes |
| Elect Director: Mohit Kaushal | 24,061,396 | -- | -- | 1,514,319 | 49,666,722 | Majority: yes |
| Elect Director: Anne McGeorge | 24,062,503 | -- | -- | 1,513,212 | 49,666,722 | Majority: yes |
| Elect Director: Mark Pacala | 24,068,647 | -- | -- | 1,507,068 | 49,666,722 | Majority: yes |
| Elect Director: Mark Stolper | 24,102,389 | -- | -- | 1,473,326 | 49,666,722 | Majority: yes |
| Elect Director: Kimberly Tzoumakas | 24,102,880 | -- | -- | 1,472,835 | 49,666,722 | Majority: yes |
| Elect Director: Daniel Virnich | 25,528,398 | -- | -- | 47,317 | 49,666,722 | Majority: yes |
| Proposal 2: Ratification of the Appointment of Independent Registered Public Accountants The ratification of the appointment of BDO USA, P.C | 75,098,890 | 37,257 | 106,290 | -- | -- | Majority: yes |
| Proposal 3: Approval, on a non-binding, advisory basis, of the Company's named executive officers (the "Say-on-Pay Proposal") The Say-on-Pay Proposal was approved | 25,280,934 | 282,655 | 12,126 | -- | 49,666,722 | Majority: yes |
Source: The Oncology Institute, Inc., Form 8-K, filed with the SEC on 2026-06-18 — read the filing on EDGAR.
Each item below shows how the 109 asset managers that disclosed a The Oncology Institute, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of The Oncology Institute, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 2 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
The Oncology Institute, Inc.’s own tally for this item (“Proposal 3: Approval, on a non-binding, advisory basis, of the Company's named executive officers (the "Say-on-Pay Proposal") The Say-on-Pay Proposal was approved”): 25,280,934 for, 282,655 against, per its Form 8-K filed 2026-06-18 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 99,982,933 outstanding shares: 25% for, 0.3% against (26% of the company cast a for/against vote).
The 107 asset managers below cast 99% of the shares they voted on this item FOR (19,078,138 for, 235,247 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,599,965 | 1 | 0 | 0 | For |
| Kanen Wealth Management LLC | 3,513,178 | 0 | 0 | 0 | For |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 3,274,985 | 0 | 0 | 0 | For |
| BlackRock | 2,180,386 | 30,046 | 0 | 0 | For |
| World Funds Trust | 1,000,000 | 0 | 0 | 0 | For |
| State Street | 589,982 | 2,319 | 0 | 0 | For |
| Ensign Peak Advisors, Inc | 578,844 | 0 | 0 | 0 | For |
| Charles Schwab | 429,805 | 0 | 0 | 0 | For |
| TIFF INVESTMENT PROGRAM | 352,849 | 0 | 0 | 0 | For |
| Northern Trust | 302,516 | 2,467 | 0 | 0 | For |
| Goldman Sachs | 260,439 | 0 | 0 | 0 | For |
| Mount Lucas Management LP | 250,000 | 0 | 0 | 0 | For |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 212,072 | 21,517 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 150,454 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 0 | 119,359 | 0 | 0 | Against |
| MARSHALL WACE, LLP | 116,254 | 0 | 0 | 0 | For |
| JPMorgan | 98,010 | 0 | 0 | 0 | For |
| HighTower Advisors, LLC | 85,862 | 0 | 0 | 0 | For |
| AQR | 83,888 | 0 | 0 | 0 | For |
| Equitable | 82,561 | 0 | 0 | 0 | For |
| Lee Financial Co | 81,362 | 0 | 0 | 0 | For |
| Lincoln Financial | 74,538 | 0 | 0 | 0 | For |
| Capital Group | 70,192 | 0 | 0 | 0 | For |
| Voya | 63,544 | 0 | 0 | 0 | For |
| AllianceBernstein | 61,600 | 0 | 0 | 0 | For |
Showing the 25 largest of 107 asset managers. See all 107 in the interactive database.
Combines 2 wordings of this item as funds reported it.
99.9% fund support · no official result
The 107 asset managers below cast 99.9% of the shares they voted on this item FOR (3,533,011 for, 370 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 0 | 0 | 0 | 0 | One Year |
| Kanen Wealth Management LLC | 3,513,178 | 0 | 0 | 0 | For |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 0 | 0 | 0 | 0 | 1 Year |
| BlackRock | 0 | 0 | 0 | 0 | 1 Year |
| World Funds Trust | 0 | 0 | 0 | 0 | 1 Year |
| State Street | 0 | 0 | 0 | 0 | One Year |
| Ensign Peak Advisors, Inc | 0 | 0 | 0 | 0 | 3 Years |
| Charles Schwab | 0 | 0 | 0 | 0 | 1 Year |
| TIFF INVESTMENT PROGRAM | 0 | 0 | 0 | 0 | 1 Year |
| Northern Trust | 0 | 0 | 0 | 0 | 1 Year |
| Goldman Sachs | 0 | 0 | 0 | 0 | One Year |
| Mount Lucas Management LP | 0 | 0 | 0 | 0 | One Year |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 0 | 0 | 0 | 0 | One Year |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | One Year |
| MELLON INVESTMENTS Corp | 0 | 0 | 0 | 0 | One Year |
| MARSHALL WACE, LLP | 0 | 0 | 0 | 0 | 1 Year |
| JPMorgan | 0 | 0 | 0 | 0 | One Year |
| HighTower Advisors, LLC | 0 | 0 | 0 | 0 | One Year |
| AQR | 0 | 0 | 0 | 0 | One Year |
| Equitable | 0 | 0 | 0 | 0 | One Year |
| Lee Financial Co | 0 | 0 | 0 | 0 | 1 Year |
| Lincoln Financial | 0 | 0 | 0 | 0 | One Year |
| Capital Group | 0 | 0 | 0 | 0 | One Year |
| Voya | 0 | 0 | 0 | 0 | One Year |
| AllianceBernstein | 0 | 0 | 0 | 0 | One Year |
Showing the 25 largest of 107 asset managers. See all 107 in the interactive database.
Combines 4 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
The Oncology Institute, Inc.’s own tally for this item (“Elect Director: Anne McGeorge”): 24,062,503 for, 1,513,212 withheld, per its Form 8-K filed 2026-06-18 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 99,982,933 outstanding shares: 24% for, 2% withheld (26% of the company cast a for/withheld vote).
The 40 asset managers below cast 100% of the shares they voted on this item FOR (11,429,755 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,180,409 | 0 | 8,191 | 0 | For |
| Kanen Wealth Management LLC | 3,513,178 | 0 | 0 | 0 | For |
| BlackRock | 1,378,086 | 0 | 0 | 0 | For |
| World Funds Trust | 1,000,000 | 0 | 0 | 0 | For |
| TIFF INVESTMENT PROGRAM | 352,849 | 0 | 0 | 0 | For |
| Charles Schwab | 214,890 | 0 | 0 | 0 | For |
| Goldman Sachs | 178,726 | 0 | 0 | 0 | For |
| JPMorgan | 98,010 | 0 | 0 | 0 | For |
| Equitable | 82,561 | 0 | 0 | 0 | For |
| Lincoln Financial | 74,538 | 0 | 0 | 0 | For |
| Fidelity | 43,046 | 0 | 0 | 0 | For |
| AQR | 39,675 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 39,638 | 0 | 0 | 0 | For |
| Global X | 34,575 | 0 | 0 | 0 | For |
| Voya | 31,772 | 0 | 0 | 0 | For |
| Pacific Life | 23,901 | 0 | 0 | 0 | For |
| John Hancock | 19,818 | 0 | 0 | 0 | For |
| Brighthouse | 17,143 | 0 | 0 | 0 | For |
| GPS Funds I | 15,839 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 14,040 | 0 | 0 | 0 | For |
| ProShares | 11,704 | 0 | 0 | 0 | For |
| TIAA | 8,810 | 0 | 0 | 0 | For |
| Northern Trust | 8,686 | 0 | 0 | 0 | For |
| SEI | 7,600 | 0 | 0 | 0 | For |
| Victory Capital | 7,386 | 0 | 0 | 0 | For |
Showing the 25 largest of 40 asset managers. See all 40 in the interactive database.
Combines 3 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
The Oncology Institute, Inc.’s own tally for this item (“Elect Director: Brad Hively”): 24,098,631 for, 1,477,084 withheld, per its Form 8-K filed 2026-06-18 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 99,982,933 outstanding shares: 24% for, 1% withheld (26% of the company cast a for/withheld vote).
The 40 asset managers below cast 100% of the shares they voted on this item FOR (11,438,471 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,183,099 | 0 | 5,502 | 0 | For |
| Kanen Wealth Management LLC | 3,513,178 | 0 | 0 | 0 | For |
| BlackRock | 1,378,086 | 0 | 0 | 0 | For |
| World Funds Trust | 1,000,000 | 0 | 0 | 0 | For |
| TIFF INVESTMENT PROGRAM | 352,849 | 0 | 0 | 0 | For |
| Charles Schwab | 214,890 | 0 | 0 | 0 | For |
| Goldman Sachs | 178,726 | 0 | 0 | 0 | For |
| JPMorgan | 98,010 | 0 | 0 | 0 | For |
| Equitable | 82,561 | 0 | 0 | 0 | For |
| Lincoln Financial | 74,538 | 0 | 0 | 0 | For |
| Fidelity | 43,046 | 0 | 0 | 0 | For |
| AQR | 39,675 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 39,638 | 0 | 0 | 0 | For |
| Global X | 34,575 | 0 | 0 | 0 | For |
| Voya | 31,772 | 0 | 0 | 0 | For |
| Pacific Life | 23,901 | 0 | 0 | 0 | For |
| John Hancock | 19,818 | 0 | 0 | 0 | For |
| Brighthouse | 17,143 | 0 | 0 | 0 | For |
| GPS Funds I | 15,839 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 14,040 | 0 | 0 | 0 | For |
| ProShares | 11,704 | 0 | 0 | 0 | For |
| TIAA | 8,810 | 0 | 0 | 0 | For |
| Northern Trust | 8,686 | 0 | 0 | 0 | For |
| SEI | 7,600 | 0 | 0 | 0 | For |
| Victory Capital | 7,386 | 0 | 0 | 0 | For |
Showing the 25 largest of 40 asset managers. See all 40 in the interactive database.
Combines 3 wordings of this item as funds reported it.
99.8% Majority: yes · of votes cast
The Oncology Institute, Inc.’s own tally for this item (“Elect Director: Daniel Virnich”): 25,528,398 for, 47,317 withheld, per its Form 8-K filed 2026-06-18 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 99,982,933 outstanding shares: 26% for, 0.1% withheld (26% of the company cast a for/withheld vote).
The 40 asset managers below cast 100% of the shares they voted on this item FOR (11,444,397 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,188,601 | 0 | 0 | 0 | For |
| Kanen Wealth Management LLC | 3,513,178 | 0 | 0 | 0 | For |
| BlackRock | 1,378,086 | 0 | 0 | 0 | For |
| World Funds Trust | 1,000,000 | 0 | 0 | 0 | For |
| TIFF INVESTMENT PROGRAM | 352,849 | 0 | 0 | 0 | For |
| Charles Schwab | 214,890 | 0 | 0 | 0 | For |
| Goldman Sachs | 178,726 | 0 | 0 | 0 | For |
| JPMorgan | 98,010 | 0 | 0 | 0 | For |
| Equitable | 82,561 | 0 | 0 | 0 | For |
| Lincoln Financial | 74,538 | 0 | 0 | 0 | For |
| Fidelity | 43,046 | 0 | 0 | 0 | For |
| AQR | 39,675 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 39,638 | 0 | 0 | 0 | For |
| Global X | 34,575 | 0 | 0 | 0 | For |
| Voya | 31,772 | 0 | 0 | 0 | For |
| Pacific Life | 23,901 | 0 | 0 | 0 | For |
| John Hancock | 19,818 | 0 | 0 | 0 | For |
| Brighthouse | 17,143 | 0 | 0 | 0 | For |
| GPS Funds I | 15,839 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 14,040 | 0 | 0 | 0 | For |
| ProShares | 11,704 | 0 | 0 | 0 | For |
| TIAA | 8,810 | 0 | 0 | 0 | For |
| Northern Trust | 8,686 | 0 | 0 | 0 | For |
| SEI | 7,600 | 0 | 0 | 0 | For |
| Victory Capital | 7,386 | 0 | 0 | 0 | For |
Showing the 25 largest of 40 asset managers. See all 40 in the interactive database.
Combines 3 wordings of this item as funds reported it.
90% Majority: yes · of votes cast
The Oncology Institute, Inc.’s own tally for this item (“Elect Director: Karen Johnson”): 23,014,174 for, 2,561,541 withheld, per its Form 8-K filed 2026-06-18 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 99,982,933 outstanding shares: 23% for, 3% withheld (26% of the company cast a for/withheld vote).
The 40 asset managers below cast 100% of the shares they voted on this item FOR (11,292,122 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,183,094 | 0 | 5,507 | 0 | For |
| Kanen Wealth Management LLC | 3,513,178 | 0 | 0 | 0 | For |
| BlackRock | 1,378,086 | 0 | 0 | 0 | For |
| World Funds Trust | 1,000,000 | 0 | 0 | 0 | For |
| TIFF INVESTMENT PROGRAM | 352,849 | 0 | 0 | 0 | For |
| Charles Schwab | 214,890 | 0 | 0 | 0 | For |
| Goldman Sachs | 178,726 | 0 | 0 | 0 | For |
| JPMorgan | 98,010 | 0 | 0 | 0 | For |
| Equitable | 82,561 | 0 | 0 | 0 | For |
| Lincoln Financial | 74,538 | 0 | 0 | 0 | For |
| Fidelity | 43,046 | 0 | 0 | 0 | For |
| AQR | 0 | 0 | 39,675 | 0 | Abstain |
| QUANTITATIVE MASTER SERIES LLC | 39,638 | 0 | 0 | 0 | For |
| Global X | 34,575 | 0 | 0 | 0 | For |
| Voya | 0 | 0 | 31,772 | 0 | Abstain |
| Pacific Life | 23,901 | 0 | 0 | 0 | For |
| John Hancock | 0 | 0 | 19,818 | 0 | Abstain |
| Brighthouse | 0 | 0 | 17,143 | 0 | Abstain |
| GPS Funds I | 15,839 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 14,040 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 11,704 | 0 | Abstain |
| TIAA | 8,810 | 0 | 0 | 0 | For |
| Northern Trust | 8,686 | 0 | 0 | 0 | For |
| SEI | 7,600 | 0 | 0 | 0 | For |
| Victory Capital | 0 | 0 | 7,386 | 0 | Abstain |
Showing the 25 largest of 40 asset managers. See all 40 in the interactive database.
Combines 3 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
The Oncology Institute, Inc.’s own tally for this item (“Elect Director: Kimberly Tzoumakas”): 24,102,880 for, 1,472,835 withheld, per its Form 8-K filed 2026-06-18 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 99,982,933 outstanding shares: 24% for, 1% withheld (26% of the company cast a for/withheld vote).
The 40 asset managers below cast 100% of the shares they voted on this item FOR (11,444,390 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,188,594 | 0 | 7 | 0 | For |
| Kanen Wealth Management LLC | 3,513,178 | 0 | 0 | 0 | For |
| BlackRock | 1,378,086 | 0 | 0 | 0 | For |
| World Funds Trust | 1,000,000 | 0 | 0 | 0 | For |
| TIFF INVESTMENT PROGRAM | 352,849 | 0 | 0 | 0 | For |
| Charles Schwab | 214,890 | 0 | 0 | 0 | For |
| Goldman Sachs | 178,726 | 0 | 0 | 0 | For |
| JPMorgan | 98,010 | 0 | 0 | 0 | For |
| Equitable | 82,561 | 0 | 0 | 0 | For |
| Lincoln Financial | 74,538 | 0 | 0 | 0 | For |
| Fidelity | 43,046 | 0 | 0 | 0 | For |
| AQR | 39,675 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 39,638 | 0 | 0 | 0 | For |
| Global X | 34,575 | 0 | 0 | 0 | For |
| Voya | 31,772 | 0 | 0 | 0 | For |
| Pacific Life | 23,901 | 0 | 0 | 0 | For |
| John Hancock | 19,818 | 0 | 0 | 0 | For |
| Brighthouse | 17,143 | 0 | 0 | 0 | For |
| GPS Funds I | 15,839 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 14,040 | 0 | 0 | 0 | For |
| ProShares | 11,704 | 0 | 0 | 0 | For |
| TIAA | 8,810 | 0 | 0 | 0 | For |
| Northern Trust | 8,686 | 0 | 0 | 0 | For |
| SEI | 7,600 | 0 | 0 | 0 | For |
| Victory Capital | 7,386 | 0 | 0 | 0 | For |
Showing the 25 largest of 40 asset managers. See all 40 in the interactive database.
Combines 3 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
The Oncology Institute, Inc.’s own tally for this item (“Elect Director: Mark Pacala”): 24,068,647 for, 1,507,068 withheld, per its Form 8-K filed 2026-06-18 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 99,982,933 outstanding shares: 24% for, 2% withheld (26% of the company cast a for/withheld vote).
The 40 asset managers below cast 100% of the shares they voted on this item FOR (11,438,471 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,183,099 | 0 | 5,502 | 0 | For |
| Kanen Wealth Management LLC | 3,513,178 | 0 | 0 | 0 | For |
| BlackRock | 1,378,086 | 0 | 0 | 0 | For |
| World Funds Trust | 1,000,000 | 0 | 0 | 0 | For |
| TIFF INVESTMENT PROGRAM | 352,849 | 0 | 0 | 0 | For |
| Charles Schwab | 214,890 | 0 | 0 | 0 | For |
| Goldman Sachs | 178,726 | 0 | 0 | 0 | For |
| JPMorgan | 98,010 | 0 | 0 | 0 | For |
| Equitable | 82,561 | 0 | 0 | 0 | For |
| Lincoln Financial | 74,538 | 0 | 0 | 0 | For |
| Fidelity | 43,046 | 0 | 0 | 0 | For |
| AQR | 39,675 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 39,638 | 0 | 0 | 0 | For |
| Global X | 34,575 | 0 | 0 | 0 | For |
| Voya | 31,772 | 0 | 0 | 0 | For |
| Pacific Life | 23,901 | 0 | 0 | 0 | For |
| John Hancock | 19,818 | 0 | 0 | 0 | For |
| Brighthouse | 17,143 | 0 | 0 | 0 | For |
| GPS Funds I | 15,839 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 14,040 | 0 | 0 | 0 | For |
| ProShares | 11,704 | 0 | 0 | 0 | For |
| TIAA | 8,810 | 0 | 0 | 0 | For |
| Northern Trust | 8,686 | 0 | 0 | 0 | For |
| SEI | 7,600 | 0 | 0 | 0 | For |
| Victory Capital | 7,386 | 0 | 0 | 0 | For |
Showing the 25 largest of 40 asset managers. See all 40 in the interactive database.
Combines 3 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
The Oncology Institute, Inc.’s own tally for this item (“Elect Director: Mark Stolper”): 24,102,389 for, 1,473,326 withheld, per its Form 8-K filed 2026-06-18 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 99,982,933 outstanding shares: 24% for, 1% withheld (26% of the company cast a for/withheld vote).
The 40 asset managers below cast 100% of the shares they voted on this item FOR (11,441,700 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,185,904 | 0 | 2,697 | 0 | For |
| Kanen Wealth Management LLC | 3,513,178 | 0 | 0 | 0 | For |
| BlackRock | 1,378,086 | 0 | 0 | 0 | For |
| World Funds Trust | 1,000,000 | 0 | 0 | 0 | For |
| TIFF INVESTMENT PROGRAM | 352,849 | 0 | 0 | 0 | For |
| Charles Schwab | 214,890 | 0 | 0 | 0 | For |
| Goldman Sachs | 178,726 | 0 | 0 | 0 | For |
| JPMorgan | 98,010 | 0 | 0 | 0 | For |
| Equitable | 82,561 | 0 | 0 | 0 | For |
| Lincoln Financial | 74,538 | 0 | 0 | 0 | For |
| Fidelity | 43,046 | 0 | 0 | 0 | For |
| AQR | 39,675 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 39,638 | 0 | 0 | 0 | For |
| Global X | 34,575 | 0 | 0 | 0 | For |
| Voya | 31,772 | 0 | 0 | 0 | For |
| Pacific Life | 23,901 | 0 | 0 | 0 | For |
| John Hancock | 19,818 | 0 | 0 | 0 | For |
| Brighthouse | 17,143 | 0 | 0 | 0 | For |
| GPS Funds I | 15,839 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 14,040 | 0 | 0 | 0 | For |
| ProShares | 11,704 | 0 | 0 | 0 | For |
| TIAA | 8,810 | 0 | 0 | 0 | For |
| Northern Trust | 8,686 | 0 | 0 | 0 | For |
| SEI | 7,600 | 0 | 0 | 0 | For |
| Victory Capital | 7,386 | 0 | 0 | 0 | For |
Showing the 25 largest of 40 asset managers. See all 40 in the interactive database.
Combines 3 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
The Oncology Institute, Inc.’s own tally for this item (“Elect Director: Mohit Kaushal”): 24,061,396 for, 1,514,319 withheld, per its Form 8-K filed 2026-06-18 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 99,982,933 outstanding shares: 24% for, 2% withheld (26% of the company cast a for/withheld vote).
The 40 asset managers below cast 100% of the shares they voted on this item FOR (11,438,471 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,183,099 | 0 | 5,502 | 0 | For |
| Kanen Wealth Management LLC | 3,513,178 | 0 | 0 | 0 | For |
| BlackRock | 1,378,086 | 0 | 0 | 0 | For |
| World Funds Trust | 1,000,000 | 0 | 0 | 0 | For |
| TIFF INVESTMENT PROGRAM | 352,849 | 0 | 0 | 0 | For |
| Charles Schwab | 214,890 | 0 | 0 | 0 | For |
| Goldman Sachs | 178,726 | 0 | 0 | 0 | For |
| JPMorgan | 98,010 | 0 | 0 | 0 | For |
| Equitable | 82,561 | 0 | 0 | 0 | For |
| Lincoln Financial | 74,538 | 0 | 0 | 0 | For |
| Fidelity | 43,046 | 0 | 0 | 0 | For |
| AQR | 39,675 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 39,638 | 0 | 0 | 0 | For |
| Global X | 34,575 | 0 | 0 | 0 | For |
| Voya | 31,772 | 0 | 0 | 0 | For |
| Pacific Life | 23,901 | 0 | 0 | 0 | For |
| John Hancock | 19,818 | 0 | 0 | 0 | For |
| Brighthouse | 17,143 | 0 | 0 | 0 | For |
| GPS Funds I | 15,839 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 14,040 | 0 | 0 | 0 | For |
| ProShares | 11,704 | 0 | 0 | 0 | For |
| TIAA | 8,810 | 0 | 0 | 0 | For |
| Northern Trust | 8,686 | 0 | 0 | 0 | For |
| SEI | 7,600 | 0 | 0 | 0 | For |
| Victory Capital | 7,386 | 0 | 0 | 0 | For |
Showing the 25 largest of 40 asset managers. See all 40 in the interactive database.
99.9% Majority: yes · of votes cast
The Oncology Institute, Inc.’s own tally for this item (“Proposal 2: Ratification of the Appointment of Independent Registered Public Accountants The ratification of the appointment of BDO USA, P.C”): 75,098,890 for, 37,257 against, per its Form 8-K filed 2026-06-18 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 99,982,933 outstanding shares: 75% for, 0.1% against (75% of the company cast a for/against vote).
The 40 asset managers below cast 100% of the shares they voted on this item FOR (11,444,397 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,188,601 | 0 | 0 | 0 | For |
| Kanen Wealth Management LLC | 3,513,178 | 0 | 0 | 0 | For |
| BlackRock | 1,378,086 | 0 | 0 | 0 | For |
| World Funds Trust | 1,000,000 | 0 | 0 | 0 | For |
| TIFF INVESTMENT PROGRAM | 352,849 | 0 | 0 | 0 | For |
| Charles Schwab | 214,890 | 0 | 0 | 0 | For |
| Goldman Sachs | 178,726 | 0 | 0 | 0 | For |
| JPMorgan | 98,010 | 0 | 0 | 0 | For |
| Equitable | 82,561 | 0 | 0 | 0 | For |
| Lincoln Financial | 74,538 | 0 | 0 | 0 | For |
| Fidelity | 43,046 | 0 | 0 | 0 | For |
| AQR | 39,675 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 39,638 | 0 | 0 | 0 | For |
| Global X | 34,575 | 0 | 0 | 0 | For |
| Voya | 31,772 | 0 | 0 | 0 | For |
| Pacific Life | 23,901 | 0 | 0 | 0 | For |
| John Hancock | 19,818 | 0 | 0 | 0 | For |
| Brighthouse | 17,143 | 0 | 0 | 0 | For |
| GPS Funds I | 15,839 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 14,040 | 0 | 0 | 0 | For |
| ProShares | 11,704 | 0 | 0 | 0 | For |
| TIAA | 8,810 | 0 | 0 | 0 | For |
| Northern Trust | 8,686 | 0 | 0 | 0 | For |
| SEI | 7,600 | 0 | 0 | 0 | For |
| Victory Capital | 7,386 | 0 | 0 | 0 | For |
Showing the 25 largest of 40 asset managers. See all 40 in the interactive database.
— fund support · no official result
No shares were cast for or against this item by the managers below — every disclosed position was an abstention or was not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| WEXFORD CAPITAL LP | 0 | 0 | 0 | 0 | One Year |
| Convergence Investment Partners, LLC | 0 | 0 | 0 | 0 | 1 |
99% Majority: yes · of votes cast
The Oncology Institute, Inc.’s own tally for this item (“Proposal 3: Approval, on a non-binding, advisory basis, of the Company's named executive officers (the "Say-on-Pay Proposal") The Say-on-Pay Proposal was approved”): 25,280,934 for, 282,655 against, per its Form 8-K filed 2026-06-18 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 99,982,933 outstanding shares: 25% for, 0.3% against (26% of the company cast a for/against vote).
The 2 asset managers below cast 100% of the shares they voted on this item FOR (1,716,011 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| WEXFORD CAPITAL LP | 1,711,323 | 0 | 0 | 0 | For |
| Convergence Investment Partners, LLC | 4,688 | 0 | 0 | 0 | For |
Ranked by the number of The Oncology Institute, Inc. shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 99,982,933 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 4.60% |
| 2 | Kanen Wealth Management LLC | 3.51% |
| 3 | DEERFIELD MANAGEMENT COMPANY, L.P. | 3.28% |
| 4 | BlackRock | 2.21% |
| 5 | World Funds Trust | 1.00% |
| 6 | State Street | 0.59% |
| 7 | Ensign Peak Advisors, Inc | 0.58% |
| 8 | Charles Schwab | 0.43% |
| 9 | TIFF INVESTMENT PROGRAM | 0.35% |
| 10 | Northern Trust | 0.31% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| Jorey Chernett | 10.50% | DEF14A |
| Chernett Jorey | 10.12% | 13G |
| Parian Global TOI LP | 9.38% | DEF14A |
| M33 Growth I L.P. | 5.00% | 13D |
| Vanguard Group | 4.75% | 13F |
| BlackRock | 4.42% | 13F |
| Citadel Advisors | 2.36% | 13F |
| Daniel Virnich | 2.21% | DEF14A |
| Geode Capital | 1.76% | 13F |
| State Street | 1.46% | 13F |
Percentages above are of 99,982,933 shares outstanding, as reported by The Oncology Institute, Inc. on its Form 10-Q dated 2026-04-30 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from The Oncology Institute, Inc.’s 10-Q dated 2026-04-30. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At The Oncology Institute, Inc.'s shareholder meeting held 2026-06-17, in the 2025-2026 proxy season, 109 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,317 separate fund positions. Their filings are grouped here into 13 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — APPROVAL, ON A NON-BINDING, ADVISORY BASIS, OF THE COMPENSATION OF THE COMPANY'S NAMED… — FOR was 99% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: The Oncology Institute, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2026-06-18.
The Oncology Institute, Inc. proxy season coverage: 2025-2026 (this page).